OMB

Senate Committee Hears Regulatory Reform Testimony

Senate Committee Hears Regulatory Reform Testimony

Senators challenge Cass Sunstein on agency reform and legislative oversight.

White House Offers Guidance on Nanotechnology Policy

White House Offers Guidance on Nanotechnology Policy

EPA, FDA respond with calls for public comments.

How Bad Math at Federal Agencies Undervalues Human Life

How Bad Math at Federal Agencies Undervalues Human Life

Agencies underestimate the value of human life by consistently ignoring health inflation and wealth inflation.

Tracking Down Killer Regulations

Tracking Down Killer Regulations

The federal government lacks an independent office to provide retrospective analysis of regulations’ costs and benefits.

EPA, NHTSA Issue New Vehicle Fuel Economy Labels

EPA, NHTSA Issue New Vehicle Fuel Economy Labels

New labels may help inform consumer choices.

Week in Review

Week in Review

Regulatory news in review

CMS Proposal on Disabled Access to Care

CMS Proposal on Disabled Access to Care

Proposal strictly defines home and community-based care.

Why Congress Should Not Codify Cost-Benefit Analysis Requirements

Why Congress Should Not Codify Cost-Benefit Analysis Requirements

Codifying cost-benefit analysis requirements of Executive Order would preempt valuable nuances of current review system.

The Myths of Benefit-Cost Analysis

The Myths of Benefit-Cost Analysis

Congress should resist the popular misconceptions of the critics of benefit-cost analysis.

House Passes Resolution Disapproving of Net Neutrality Rules

House Passes Resolution Disapproving of Net Neutrality Rules

Democrats and Republicans disagree about FCC’s role in Internet access.

Week in Review

Week in Review

Regulatory news in review

Agency Calculations of the Value of Statistical Lives Saved

Agency Calculations of the Value of Statistical Lives Saved

Regulatory agencies change monetary values used when analyzing life-saving regulations.